<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04973540</url>
  </required_header>
  <id_info>
    <org_study_id>IBS Angel-01</org_study_id>
    <nct_id>NCT04973540</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis</brief_title>
  <acronym>IRIS</acronym>
  <official_title>A Prospective, Multi-center, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of Iron Bioresorbable Scaffold System (IBS Angel) in Patients With Pulmonary Artery Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotyx Medical (Shenzhen) Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotyx Medical (Shenzhen) Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, single-arm clinical trial to evaluate the safety and&#xD;
      efficacy of Iron Bioresorbable Scaffold System (IBS Angel) in patients with pulmonary artery&#xD;
      stenosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      82 patients with pulmonary artery stenosis will be treated with the Iron Bioresorbable&#xD;
      Scaffold System (IBS Angel) developed by Biotyx Medical (Shenzhen) Co., Ltd. This study is&#xD;
      designed as a prospective, multi-center, single-arm clinical trial. Enrolled patients will&#xD;
      undergo IBS Angel implantation and will be followed up at 1, 3, 6, 12, and 24 months&#xD;
      post-procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 13, 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of freedom from in-stent restenosis</measure>
    <time_frame>12 months</time_frame>
    <description>Defined on a per target lesion basis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of procedural success</measure>
    <time_frame>Immediately post-procedure</time_frame>
    <description>Defined on a per target lesion basis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of technical success</measure>
    <time_frame>Immediately post-procedure</time_frame>
    <description>Defined on a per target lesion basis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of freedom from in-stent restenosis</measure>
    <time_frame>1 month</time_frame>
    <description>Defined on a per target lesion basis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of freedom from in-stent restenosis</measure>
    <time_frame>3 months</time_frame>
    <description>Defined on a per target lesion basis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of freedom from in-stent restenosis</measure>
    <time_frame>6 months</time_frame>
    <description>Defined on a per target lesion basis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related adverse events</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related serious adverse events</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related adverse events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related serious adverse events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related serious adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related serious adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related adverse events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related serious adverse events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned surgery or re-intervention</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned surgery or re-intervention</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned surgery or re-intervention</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned surgery or re-intervention</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned surgery or re-intervention</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent thrombosis</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent thrombosis</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent thrombosis</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent thrombosis</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent thrombosis</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause death</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause death</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause death</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of all-cause death</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent displacement</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent displacement</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent displacement</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of stent displacement</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of serious adverse events</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of serious adverse events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of serious adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of serious adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of serious adverse events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device deficiency</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Pulmonary Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>IBS Angel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iron Bioresorbable Scaffold System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Iron Bioresorbable Scaffold System (IBS Angel)</intervention_name>
    <description>Subjects in this arm will be implanted with IBS Angel.</description>
    <arm_group_label>IBS Angel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients must between 1 and 14 years old.&#xD;
&#xD;
          2. Patients who have congenital or secondary pulmonary artery stenosis (including&#xD;
             pulmonary artery trunk, left pulmonary artery and right pulmonary artery), and meeting&#xD;
             one of the following criteria:&#xD;
&#xD;
             A: The pressure gradient across the stenosis ≥20mmHg measured by catheter; B: The&#xD;
             degree of pulmonary artery stenosis ≥50% ( calculated by (diameter of adjacent normal&#xD;
             segments - residual lumen diameter of the stenosis segment)/diameter of adjacent&#xD;
             normal segments ×100%); C: The ratio of right ventricular systolic pressure to aortic&#xD;
             systolic pressure ≥50%.&#xD;
&#xD;
          3. Patients and whose family have high compliance, voluntarily participate in and sign&#xD;
             the informed consent form, and complete the 2-year follow-up.&#xD;
&#xD;
          4. Patients have life expectancy &gt;2 year after successful stent implantation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who have a history of disease related to iron overload or iron disorder, such&#xD;
             as hereditary hemochromatosis, etc.&#xD;
&#xD;
          2. Patients with cardiopulmonary function that cannot tolerate surgery, such as severe&#xD;
             heart failure (NYHA Grade III and above) that cannot be controlled by active medical&#xD;
             treatment.&#xD;
&#xD;
          3. Patients with known allergy to contrast agent, iron and its degradation products.&#xD;
&#xD;
          4. Patients with hemorrhagic disorders.&#xD;
&#xD;
          5. Patients with contraindications on antiplatelet agents and anticoagulant therapy.&#xD;
&#xD;
          6. Patients with thrombosis at the vascular wall of target lesion or the distal or&#xD;
             proximal location.&#xD;
&#xD;
          7. Patients with known severe renal or hepatic insufficiency which are unsuitable for&#xD;
             index procedure as per investigator judgement.&#xD;
&#xD;
          8. Previous stent implantation has been performed to treat the target lesion;&#xD;
&#xD;
          9. Patients with severe stenosis or excessive tortuosity in the targeted vessels, or&#xD;
             anatomical abnormalities, making it difficult for device to reach the target lesion.&#xD;
&#xD;
         10. Other conditions that are not suitable for stent delivery or balloon expansion.&#xD;
&#xD;
         11. Patient who have already participated in another drug or medical device clinical trial&#xD;
             that have not yet completed or withdrawn within 3 months before the screening period&#xD;
             of this trial.&#xD;
&#xD;
         12. Patients who are not suitable for participating the trial as per investigator&#xD;
             judgement.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ying Xia</last_name>
    <phone>86 13760184511</phone>
    <email>xiaying@lifetechmed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Zhenfei Fang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Qijian Yi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Gaozhou</name>
      <address>
        <city>Gaozhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lian Hu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Zhiwei Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fuwai Yunnan Cardiovascular Hospital</name>
      <address>
        <city>Kunming</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Gejun Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Fen Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Sun Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Northern Theater Command of Chinese People's Liberation Army</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Qiguang Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shenzhen Children's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Boning Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fuwai Central China Cardiovascular Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Taibing Fan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stenosis, Pulmonary Artery</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

